Stuttgart - Delayed Quote EUR
Sangamo Therapeutics Inc (GBY.SG)
0.6316
+0.0150
+(2.43%)
As of 3:35:03 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-67,139
-67,139
-224,842
-223,627
-233,251
Investing Cash Flow
37,524
37,524
153,531
59,285
248,199
Financing Cash Flow
28,377
28,377
14,588
84,660
32,858
End Cash Position
43,418
43,418
46,704
101,944
180,372
Capital Expenditure
-267
-267
-21,155
-20,171
-23,278
Issuance of Capital Stock
28,991
28,991
15,106
84,869
27,099
Free Cash Flow
-67,406
-67,406
-245,997
-243,798
-256,529
12/31/2021 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCT.TO BriaCell Therapeutics Corp.
5.05
-4.72%
MDNA.TO Medicenna Therapeutics Corp.
1.0100
-2.88%
SKYE Skye Bioscience, Inc.
1.8700
-6.03%
OSTX OS Therapies Incorporated
2.2500
+2.27%
VTGN Vistagen Therapeutics, Inc.
2.2750
-3.20%
ABCL AbCellera Biologics Inc.
2.1450
-2.05%
SLS SELLAS Life Sciences Group, Inc.
1.6750
-2.05%